Parabilis Medicines

(NASDAQ) PBLS

Current Price$26.10

Market Cap$87.08M

Since IPO (2026)-16%

5 YearN/A

1 YearN/A

1 MonthN/A

Parabilis Medicines Financials at a Glance

Market Cap

$87.08M

Revenue (TTM)

$0.00

Net Income (TTM)

-$83.64

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-19.98 (Low)

Dividend

$0.00

Beta (Volatility)

-19.98 (Low)

Price

$26.10

Volume

49,639

Open

$28.52

Price

$26.10

Volume

49,639

Open

$28.52

Previous Close

$26.10

Daily Range

$26.04 - $28.52

52-Week Range

$20.00 - $34.47

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

-19.98 (Low)

Price

$26.10

Volume

49,639

Open

$28.52

Previous Close

$26.10

Daily Range

$26.04 - $28.52

52-Week Range

$20.00 - $34.47

Estimated Earnings Date

N/A

PBLS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Parabilis Medicines

Industry

Pharmaceuticals

Sector

Health Care

Employees

176

CEO

Mathai Mammen, MD, PhD

Website

parabilismed.com

Headquarters

Cambridge, MA 02140, US

PBLS Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$87.08M

Shares Outstanding

3.27M

Volume

49.64K

Avg. Volume

2.13M

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Parabilis Medicines Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$0.61

N/A

Gross Margin

N/A

Market Cap

$87.08M

N/A

Market Cap/Employee

N/A

Employees

176

N/A

Net Income

-$45.32

N/A

EBITDA

-$46.85

N/A

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$382.19

N/A

Total Debt

$53.15

N/A

Accounts Receivable

N/A

Inventory

$0.00

N/A

Long Term Debt

$35.71

N/A

Short Term Debt

$17.43

N/A

Return on Assets

N/A

Return on Invested Capital

N/A

Free Cash Flow

-$49.57

N/A

Operating Cash Flow

-$49.20

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,464.81-0.01%

^DJIDJI

^DJIDJI$51,908.68-0.00%

^IXICNASDAQ

^IXICNASDAQ$26,223.50-0.01%

BTCBitcoin

BTCBitcoin$65,390.00-0.01%

SPCXSPCX

SPCXSPCX$196.92-0.02%

AAPLAAPL

AAPLAAPL$295.77-0.01%

AMZNAMZN

AMZNAMZN$239.09-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ICCMIceCure Medical

ICCMIceCure Medical$6.40+2.00%

AALAmerican Airlines Group

AALAmerican Airlines Group$15.42-0.02%

SOFISoFi Technologies

SOFISoFi Technologies$17.42-0.02%

NOKNokia

NOKNokia$13.83-0.01%

NUNu Holdings

NUNu Holdings$12.89+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.54-0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$39.52+0.03%

Questions About PBLS

What is the current price of Parabilis Medicines?

Parabilis Medicines is trading at $26.10 per share.

What is the 52-week range for Parabilis Medicines?

Over the past 52 weeks, Parabilis Medicines has traded between $20.00 and $34.47.

How much debt does Parabilis Medicines have?

As of the most recent reporting period, Parabilis Medicines reported total debt of $53.15M.

How much cash does Parabilis Medicines have on hand?

Parabilis Medicines reported $329.04M in cash and cash equivalents in its most recent financial results.

What is Parabilis Medicines’s dividend yield?

Parabilis Medicines does not currently have a dividend yield.

Parabilis Medicines

Parabilis Medicines Financials at a Glance

PBLS News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Parabilis Medicines

PBLS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Parabilis Medicines Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PBLS

What is the current price of Parabilis Medicines?

What is the 52-week range for Parabilis Medicines?

How much debt does Parabilis Medicines have?

How much cash does Parabilis Medicines have on hand?

What is Parabilis Medicines’s dividend yield?

Premium Investing Services